Mitra Biotech scales-up operations with Sequoia, Sands Capital Ventures’ funding

2016-08-29 10:32:11

Mitra Biotech has raised $27.4 million in a series B financing round from Sequoia Capital India, Washington-based Sands Capital Ventures and RA Capital Management.By Team ABLEBengaluru-based Mitra Biotech that specializes in cancer treatment and drug development has raised $27.4 million in a series B financing round from Sequoia Capital India, Washington-based Sands Capital Ventures, and RA Capita

Read more

“A country’s backbone is its Bioeconomy. ABLE is spending a lot of time on young minds as well,” Mr Panchapagesa Murali

2016-08-27 15:29:55

In this week’s conversation with Narayanan Suresh, Mr  Panchapagesa Murali, shares his views on how to move forward in the changing environs of the biotech business, investment climate, and regulatory affairs. Mr Murali is the President of the Association of Biotechnology Led Enterprises in India.  Mr Murali is also Managing Director & CEO, Evolva India. The ABLE editorial tea

Read more

WhyCI Inc to host India’s First Pharma & Biotech Competitive Intelligence Conference in Mumbai

2016-08-27 15:15:20

The event, partnered by Association of Biotechnology-Led Enterprises (ABLE), has special rates for participation for members. By Team ABLECompetitive Intelligence (CI) is a process of giving the businesses insight into what might happen in the near future. The way companies acquire information about their competitors from the markets and convert it into opportunities, determines the company

Read more

Monsanto withdraws application of new GM cotton

2016-08-27 15:04:27

Monsanto Co. withdrew an application to sell a new variety of genetically modified cotton seed in India because of its concerns over the country’s attempts to restrict the biotechnology business.Team ABLELeading agriculture company, Monsanto, has decided to withdraw an application seeking approval for its next generation of genetically modified cotton seeds in India. The application was for Boll

Read more

India assists Belarus Government to set up antiretroviral manufacturing facility

2016-08-26 05:47:18

India has been assisting Belarus Government in establishing a pharmaceutical enterprise called JivaPharm which will be built in Kolyadichi in Minsk to make antiretroviral medications.By Team ABLEAccording to The Belarusian Telegraph Agency (BelTA), a Belarusian-Indian pharmaceutical enterprise JivaPharm will be established in Kolyadichi located in Minsk, Belarus. The enterprise will occupy 4.63ha.

Read more

Aurobindo Pharma to increase focus on specialty generics as primary growth strategy

2016-08-26 05:45:13

The first quarter (Q1) results of 2016-17 started with a double digit Year-on-Year growth on the back of overall business performance for Aurobindo. With focus on execution and capability enhancements, the company will continue to progress on specialty generics for a sustained long term growth.By Team ABLEAurobindo Pharma Ltd has released its first quarter results for Financial Year 2016-17. The h

Read more

Adocia’s BioChaperone for diabetic foot Ulcer disappoints in phase III trials results

2016-08-26 05:43:03

BioChaperone PDGF (BC PDGF) used in the treatment of diabetic foot ulcer did not meet the primary endpoint in phase III trial conducted in IndiaBy Team ABLEParis-based Adocia biopharmaceutical company has announced the results from a phase III clinical trial of BioChaperone PDGF (BC PDGF) in the treatment of diabetic foot ulcer (DFU), which was conducted in India. In this trial, BC PDGF did not me

Read more

European Medicines Agency accepts regulatory submission for proposed biosimilar, Trastuzumab, by Biocon and Mylan

2016-08-25 12:29:54

Biocon-Mylan announce regulatory acceptance of submission of their proposed second biosimilar, Trastuzumab after PegfilgrastimBy Team ABLEThe European Medicines Agency (EMA) has accepted for review Mylan’s Marketing Authorization Application (MAA) for a proposed biosimilar Trastuzumab. This is used to treat certain HER2-positive breast and gastric cancers. This is the second biosimilar submissio

Read more

AstraZeneca sells small molecule antibiotics business to Pfizer

2016-08-25 10:15:48

This deal will help AstraZeneca focus on three main therapy areas, while Pfizer’s dedicated focus on infectious diseases is expected to extend the reach of the antibiotics to more patients globally and maximize the potential of the late-stage, small molecule antibiotics business.By Team ABLEIn a significant development, AstraZeneca announced that the company has entered into an agreement with bi

Read more

Ministry of AYUSH, US Pharmacopeial Convention partner to strengthen quality of traditional medicine

2016-08-25 10:11:38

Ministry of AYUSH and the United States Pharmacopeial Convention (USP) have signed an MoU to promote the safety, quality and integrity of traditional medicines and botanical dietary supplementsBy Team ABLEThe Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) under the Ministry of AYUSH and the United States Pharmacopeial Convention (USP) have signed a Memorandum of Unders

Read more